Product Overview
[Drug Name]
Generic Name: Silibinin Capsules
Trade Name: Shuilinjia/Tianshili
English Name: Silibinin Capsules
Chinese Pinyin: Shuifeijibing Jiaonang
[Ingredients]
The main ingredient is a flavonoid compound isolated from the fruit of the Silybum marianum plant, Silybum marianum.
[Properties]
Hard capsules containing an off-white or light yellow powder.
[Indications]
For the recovery of liver function abnormalities in acute and chronic hepatitis and fatty liver.
[Dosage and Administration]
Oral administration: Adults, 2-4 capsules three times daily. Or as directed by a physician.
[Adverse Reactions]
Mainly mild gastrointestinal symptoms (nausea, hiccups) and chest tightness.
[Contraindications]
Not yet known.
[Precautions]
Use with caution in patients with allergies to this product.
[Use in Special Populations]
Precautions for children: No adverse reactions have been reported. Please follow your physician's advice. Precautions for Pregnancy and Lactation: The safety of this medication for pregnant and lactating women has not been established. Please follow your doctor's advice.
Precautions for Elderly Patients: No adverse reactions have been reported. Please follow your doctor's advice.
[Drug Interactions]
Drug interactions may occur if used with other medications. Please consult your doctor or pharmacist for details.
[Pharmacological Actions]
Silibinin stabilizes liver cell membranes, protects liver cell enzyme systems, and scavenges reactive oxygen free radicals within liver cells, thereby enhancing the liver's detoxification capacity and protecting liver cells from damage caused by long-term exposure to toxins, use of hepatotoxic drugs, smoking, and alcohol.
[Storage]
Store tightly closed in a dry place at room temperature.
[Specification]
35mg x 20 tablets
[Packaging Size]
Box
[Expiration Period]
24 months
[Approval Number]
National Medicine Standard H20040299
[Manufacturer]
Company Name: Tianjin Tasly Shengte Pharmaceutical Co., Ltd.
